MRK: Merck & Co., Inc. Financials
Merck & Co., Inc. Income Statement
Total revenue
Net income
Gross margin TTM
71.98%
Operating margin TTM
36.17%
Net profit margin TTM
28.12%
Return on investment TTM
34.7%
| Period end | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 |
|---|---|---|---|---|
| Total revenue | 64,926,000,000 | 64,168,000,000 | 60,115,000,000 | 59,283,000,000 |
| Operating income | 23,486,000,000 | 20,221,000,000 | 2,954,000,000 | 18,282,000,000 |
| Net income | 18,254,000,000 | 17,117,000,000 | 365,000,000 | 14,519,000,000 |
All line items
| Line item | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 |
|---|---|---|---|---|
| Total revenue | 64,926,000,000 | 64,168,000,000 | 60,115,000,000 | 59,283,000,000 |
| Cost of revenue | 18,195,000,000 | 15,193,000,000 | 16,126,000,000 | 17,411,000,000 |
| Gross profit | 46,731,000,000 | 48,975,000,000 | 43,989,000,000 | 41,872,000,000 |
| Research and development expenses | 12,514,000,000 | 17,938,000,000 | 30,531,000,000 | 13,548,000,000 |
| General and administrative expenses | 0 | 7,700,000,000 | 7,584,000,000 | 7,469,000,000 |
| Selling and marketing expenses | 0 | 2,400,000,000 | 2,300,000,000 | 2,200,000,000 |
| Selling, general and administrative expenses | 10,731,000,000 | 10,100,000,000 | 9,884,000,000 | 9,669,000,000 |
| Other expenses | 0 | 716,000,000 | 620,000,000 | 373,000,000 |
| Operating expenses | 23,245,000,000 | 28,754,000,000 | 41,035,000,000 | 23,590,000,000 |
| Cost and expenses | 41,440,000,000 | 43,947,000,000 | 57,161,000,000 | 41,001,000,000 |
| Net interest income | -1,014,000,000 | -856,000,000 | -781,000,000 | -805,000,000 |
| Interest income | 343,000,000 | 415,000,000 | 365,000,000 | 157,000,000 |
| Interest expense | 1,357,000,000 | 1,271,000,000 | 1,146,000,000 | 962,000,000 |
| Depreciation and amortization | 5,838,000,000 | 4,499,000,000 | 3,872,000,000 | 3,909,000,000 |
| EBITDA | 28,262,000,000 | 25,706,000,000 | 6,907,000,000 | 21,315,000,000 |
| EBIT | 22,424,000,000 | 21,207,000,000 | 3,035,000,000 | 17,406,000,000 |
| Non-operating income (excl. interest) | 1,062,000,000 | -986,000,000 | -81,000,000 | 876,000,000 |
| Operating income | 23,486,000,000 | 20,221,000,000 | 2,954,000,000 | 18,282,000,000 |
| Total other income/expenses (net) | -2,419,000,000 | -285,000,000 | -1,065,000,000 | -1,838,000,000 |
| Income before tax | 21,067,000,000 | 19,936,000,000 | 1,889,000,000 | 16,444,000,000 |
| Income tax expense | 2,804,000,000 | 2,803,000,000 | 1,512,000,000 | 1,918,000,000 |
| Net income from continuing operations | 18,263,000,000 | 17,133,000,000 | 377,000,000 | 14,526,000,000 |
| Net income from discontinued operations | 0 | 0 | 0 | 0 |
| Other adjustments to net income | 0 | 0 | 0 | 0 |
| Net income | 18,254,000,000 | 17,117,000,000 | 365,000,000 | 14,519,000,000 |
| Net income deductions | 0 | 0 | 0 | 0 |
| Bottom line net income | 18,254,000,000 | 17,117,000,000 | 365,000,000 | 14,519,000,000 |
| EPS | 7 | 7 | 0.14 | 6 |
| Diluted EPS | 7 | 7 | 0.14 | 6 |
| Weighted average shares outstanding | 2,502,000,000 | 2,532,000,000 | 2,607,143,000 | 2,532,000,000 |
| Weighted average diluted shares outstanding | 2,507,000,000 | 2,541,000,000 | 2,547,000,000 | 2,542,000,000 |
Merck & Co., Inc. Balance Sheet
Total assets
Total liabilities & equity
Liquidity ratio MRQ
—
Current ratio MRQ
—
Long-term debt / assets MRQ
46,750,000,000%
Total debt / assets MRQ
—
| Period end | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 |
|---|---|---|---|---|
| Total assets | 136,866,000,000 | 117,106,000,000 | 106,675,000,000 | 109,160,000,000 |
| Total liabilities | 84,204,000,000 | 70,734,000,000 | 69,040,000,000 | 63,102,000,000 |
| Total equity | 52,606,000,000 | 46,313,000,000 | 37,581,000,000 | 45,991,000,000 |
All line items
| Line item | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 |
|---|---|---|---|---|
| Cash and cash equivalents | 14,565,000,000 | 13,242,000,000 | 6,841,000,000 | 12,694,000,000 |
| Short-term investments | 0 | 447,000,000 | 252,000,000 | 498,000,000 |
| Cash and short-term investments | 14,565,000,000 | 13,689,000,000 | 7,093,000,000 | 13,192,000,000 |
| Net receivables | 12,679,000,000 | 10,278,000,000 | 10,349,000,000 | 9,450,000,000 |
| Accounts receivable | 11,775,000,000 | 10,278,000,000 | 10,349,000,000 | 9,450,000,000 |
| Other receivables | 904,000,000 | 0 | 0 | 0 |
| Inventory | 6,658,000,000 | 6,109,000,000 | 6,358,000,000 | 5,911,000,000 |
| Prepaid expenses | 0 | 0 | 0 | 0 |
| Other current assets | 9,489,000,000 | 8,706,000,000 | 8,368,000,000 | 7,169,000,000 |
| Total current assets | 43,516,000,000 | 38,782,000,000 | 32,168,000,000 | 35,722,000,000 |
| Property, plant and equipment (net) | 26,823,000,000 | 23,779,000,000 | 23,051,000,000 | 21,422,000,000 |
| Goodwill | 21,579,000,000 | 21,668,000,000 | 21,197,000,000 | 21,204,000,000 |
| Intangible assets | 26,681,000,000 | 16,370,000,000 | 18,011,000,000 | 20,269,000,000 |
| Goodwill and intangible assets | 48,260,000,000 | 38,038,000,000 | 39,208,000,000 | 41,473,000,000 |
| Long-term investments | 2,239,000,000 | 463,000,000 | 252,000,000 | 1,015,000,000 |
| Tax assets | 0 | 0 | 0 | 0 |
| Other non-current assets | 16,028,000,000 | 16,044,000,000 | 11,996,000,000 | 9,528,000,000 |
| Total non-current assets | 93,350,000,000 | 78,324,000,000 | 74,507,000,000 | 73,438,000,000 |
| Other assets | 0 | 0 | 0 | 0 |
| Total assets | 136,866,000,000 | 117,106,000,000 | 106,675,000,000 | 109,160,000,000 |
| Total payables | 11,270,000,000 | 10,077,000,000 | 8,556,000,000 | 8,134,000,000 |
| Accounts payable | 4,404,000,000 | 4,079,000,000 | 3,922,000,000 | 4,264,000,000 |
| Other payables | 6,866,000,000 | 5,998,000,000 | 4,634,000,000 | 3,870,000,000 |
| Accrued expenses | 85,000,000 | 15,694,000,000 | 15,766,000,000 | 14,159,000,000 |
| Short-term debt | 2,883,000,000 | 2,649,000,000 | 1,372,000,000 | 1,946,000,000 |
| Capital lease obligations (current) | 0 | 282,000,000 | 285,000,000 | 281,000,000 |
| Tax payables | 0 | 3,914,000,000 | 2,649,000,000 | 1,986,000,000 |
| Deferred revenue | 0 | 0 | 0 | 0 |
| Other current liabilities | 14,089,000,000 | -282,000,000 | -285,000,000 | -281,000,000 |
| Total current liabilities | 28,327,000,000 | 28,420,000,000 | 25,694,000,000 | 24,239,000,000 |
| Long-term debt | 46,750,000,000 | 34,462,000,000 | 33,683,000,000 | 28,745,000,000 |
| Capital lease obligations (non-current) | 901,000,000 | 877,000,000 | 928,000,000 | 1,013,000,000 |
| Deferred revenue (non-current) | 0 | 0 | 0 | 0 |
| Deferred tax liabilities (non-current) | 1,439,000,000 | 1,387,000,000 | 871,000,000 | 1,795,000,000 |
| Other non-current liabilities | 6,787,000,000 | 5,588,000,000 | 7,864,000,000 | 7,310,000,000 |
| Total non-current liabilities | 55,877,000,000 | 42,314,000,000 | 43,346,000,000 | 38,863,000,000 |
| Other liabilities | 0 | 0 | 0 | 0 |
| Capital lease obligations | 901,000,000 | 1,159,000,000 | 1,213,000,000 | 1,294,000,000 |
| Total liabilities | 84,204,000,000 | 70,734,000,000 | 69,040,000,000 | 63,102,000,000 |
| Treasury stock | -62,999,000,000 | -58,303,000,000 | -57,450,000,000 | -56,489,000,000 |
| Preferred stock | 0 | 0 | 0 | 0 |
| Common stock | 1,788,000,000 | 1,788,000,000 | 1,788,000,000 | 1,788,000,000 |
| Retained earnings | 73,075,000,000 | 63,069,000,000 | 53,895,000,000 | 61,081,000,000 |
| Additional paid-in capital | 45,029,000,000 | 44,704,000,000 | 44,509,000,000 | 44,379,000,000 |
| Accumulated other comprehensive income/loss | -4,287,000,000 | -4,945,000,000 | -5,161,000,000 | -4,768,000,000 |
| Other stockholders' equity | 0 | 0 | 0 | 0 |
| Total stockholders' equity | 52,606,000,000 | 46,313,000,000 | 37,581,000,000 | 45,991,000,000 |
| Total equity | 52,662,000,000 | 46,372,000,000 | 37,635,000,000 | 46,058,000,000 |
| Minority interest | 56,000,000 | 59,000,000 | 54,000,000 | 67,000,000 |
| Total liabilities and total equity | 136,866,000,000 | 117,106,000,000 | 106,675,000,000 | 109,160,000,000 |
| Total investments | 2,239,000,000 | 910,000,000 | 504,000,000 | 1,513,000,000 |
| Total debt | 50,534,000,000 | 38,270,000,000 | 36,268,000,000 | 31,985,000,000 |
| Net debt | 35,969,000,000 | 25,028,000,000 | 29,427,000,000 | 19,291,000,000 |
Merck & Co., Inc. Cash Flow Statement
Cash from operations
Cash from investing
Cash flow / share TTM
—
Revenue / share TTM
—
Operating cash flow TTM
—
| Period end | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 |
|---|---|---|---|---|
| Cash from operations | 16,472,000,000 | 21,468,000,000 | 13,006,000,000 | 19,095,000,000 |
| Cash from investing | -13,741,000,000 | -7,734,000,000 | -14,083,000,000 | -4,960,000,000 |
| Cash from financing | -1,922,000,000 | -7,032,000,000 | -4,810,000,000 | -9,119,000,000 |
| Net change in cash | 1,372,000,000 | 6,409,000,000 | -5,864,000,000 | 4,606,000,000 |
All line items
| Line item | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 |
|---|---|---|---|---|
| Net income | 18,254,000,000 | 17,133,000,000 | 365,000,000 | 14,526,000,000 |
| Depreciation and amortization | 5,838,000,000 | 4,499,000,000 | 3,872,000,000 | 3,909,000,000 |
| Deferred income tax | -1,671,000,000 | -1,249,000,000 | -1,899,000,000 | -1,568,000,000 |
| Stock-based compensation | 0 | 761,000,000 | 645,000,000 | 541,000,000 |
| Change in working capital | -6,976,000,000 | -3,667,000,000 | -2,205,000,000 | -2,782,000,000 |
| Accounts receivable | -1,090,000,000 | -244,000,000 | -1,148,000,000 | -644,000,000 |
| Inventory | -1,180,000,000 | -835,000,000 | -816,000,000 | -161,000,000 |
| Accounts payable | 110,000,000 | 182,000,000 | -380,000,000 | -289,000,000 |
| Other working capital | -4,816,000,000 | -2,770,000,000 | 139,000,000 | -1,688,000,000 |
| Other non-cash items | 1,027,000,000 | 3,991,000,000 | 12,228,000,000 | 4,469,000,000 |
| Net cash from operating activities | 16,472,000,000 | 21,468,000,000 | 13,006,000,000 | 19,095,000,000 |
| Investments in property, plant and equipment | -4,112,000,000 | -3,372,000,000 | -3,863,000,000 | -4,388,000,000 |
| Acquisitions (net) | -10,042,000,000 | -4,093,000,000 | -12,032,000,000 | -121,000,000 |
| Purchases of investments | -1,207,000,000 | -519,000,000 | -955,000,000 | -1,204,000,000 |
| Sales/maturities of investments | 1,678,000,000 | 377,000,000 | 1,658,000,000 | 721,000,000 |
| Other investing activities | -58,000,000 | -127,000,000 | 1,109,000,000 | 32,000,000 |
| Net cash from investing activities | -13,741,000,000 | -7,734,000,000 | -14,083,000,000 | -4,960,000,000 |
| Net debt issuance | 11,377,000,000 | 2,309,000,000 | 4,184,000,000 | -2,251,000,000 |
| Long-term net debt issuance | 11,377,000,000 | 2,309,000,000 | 4,184,000,000 | -2,251,000,000 |
| Short-term net debt issuance | 0 | 0 | 0 | 0 |
| Net stock issuance | -4,992,000,000 | -1,306,000,000 | -1,346,000,000 | 384,000,000 |
| Net common stock issuance | -4,992,000,000 | -1,306,000,000 | -1,346,000,000 | 384,000,000 |
| Common stock issuance | 92,000,000 | 0 | 0 | 384,000,000 |
| Common stock repurchased | -5,084,000,000 | -1,306,000,000 | -1,346,000,000 | 0 |
| Net preferred stock issuance | 0 | 0 | 0 | 0 |
| Net dividends paid | -8,176,000,000 | -7,840,000,000 | -7,445,000,000 | -7,012,000,000 |
| Common dividends paid | -8,176,000,000 | -7,840,000,000 | -7,445,000,000 | -7,012,000,000 |
| Preferred dividends paid | 0 | 0 | 0 | 0 |
| Other financing activities | -131,000,000 | -195,000,000 | -203,000,000 | -240,000,000 |
| Net cash from financing activities | -1,922,000,000 | -7,032,000,000 | -4,810,000,000 | -9,119,000,000 |
| Effect of FX changes on cash | 563,000,000 | -293,000,000 | 23,000,000 | -410,000,000 |
| Net change in cash | 1,372,000,000 | 6,409,000,000 | -5,864,000,000 | 4,606,000,000 |
| Cash at end of period | 14,690,000,000 | 13,318,000,000 | 6,909,000,000 | 12,773,000,000 |
| Cash at beginning of period | 13,318,000,000 | 6,909,000,000 | 12,773,000,000 | 8,167,000,000 |
| Operating cash flow | 16,472,000,000 | 21,468,000,000 | 13,006,000,000 | 19,095,000,000 |
| Capital expenditure | -4,112,000,000 | -3,372,000,000 | -3,863,000,000 | -4,388,000,000 |
| Free cash flow | 12,360,000,000 | 18,096,000,000 | 9,143,000,000 | 14,707,000,000 |
| Income taxes paid | 0 | 0 | 0 | 0 |
| Interest paid | 0 | 0 | 0 | 0 |